{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:57:17Z","timestamp":1777312637142,"version":"3.51.4"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100003896","name":"Henry M. Jackson Foundation","doi-asserted-by":"publisher","award":["#N62645-14-C-4034"],"award-info":[{"award-number":["#N62645-14-C-4034"]}],"id":[{"id":"10.13039\/100003896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["#HHSN272201700037I\/HHSN27200003\/B04"],"award-info":[{"award-number":["#HHSN272201700037I\/HHSN27200003\/B04"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Venezuelan equine encephalitis virus (VEEV) is a mosquito-borne RNA virus that causes low mortality but high morbidity in humans. In addition to natural outbreaks, there is potential for exposure to VEEV via aerosolized virus particles. Currently there are no FDA-licensed vaccines or antiviral therapies for VEEV. We previously demonstrated that high titer anti-VEEV human antibody preparations derived from the plasma of hyperimmunized transchromosomic (Tc) bovines provided significant protection to mice from subcutaneous and aerosol challenge with virulent VEEV (Gardner et al.,\n                    <jats:italic>J. Virol.<\/jats:italic>\n                    , 91:e00226-17, 2017). In the current studies we utilized the cynomolgus macaque primate model of VEEV infection, challenging some treatment groups with either a IA\/B clade virus or a IC clade virus, each derived from a cDNA clone. Animals were treated with liquid or lyophilized transchromosomic bovine polyclonal antibody (TcpAb) preparations via intravenous (IV) or intranasal (IN) routes. Single dose prophylactic (24\u2009hr before challenge) treatment with the liquid TcpAb given IV yielded significant reduction in the magnitude and\/or extent of febrile responses and eliminated or greatly reduced serum infectious viremia\n                    <jats:italic>versus<\/jats:italic>\n                    control after aerosol challenge with VEEV regardless of subtype. Therapeutic (24\u2009hr after challenge) treatment showed similar results with the IA\/B virus. However, IN treatment alone with lyophilized TcpAb was ineffective against the IC virus. These results indicate that IV treatment with the TcpAb is effective in reducing VEEV disease severity in non-human primates and may be a useful single treatment strategy for infections with this emerging virus.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0347864","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:24:19Z","timestamp":1777310659000},"page":"e0347864","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["A single dose of purified human antibody from transchromosomic bovines mitigates aerosolized Venezuelan equine encephalitis virus disease in cynomolgus macaques"],"prefix":"10.1371","volume":"21","author":[{"given":"Chengqun","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9700-4988","authenticated-orcid":true,"given":"Long Kwan Metthew","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeneveve","family":"Lundy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"O\u2019Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Luke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanakatte","family":"Raviprakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy L.","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas A.","family":"Crossland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-an","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Bausch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eddie","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas S.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4506-7842","authenticated-orcid":true,"given":"William B.","family":"Klimstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"3","key":"pone.0347864.ref001","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4269\/ajtmh.1999.60.441","article-title":"Genetic evidence for the origins of Venezuelan equine encephalitis virus subtype IAB outbreaks","volume":"60","author":"SC Weaver","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"pone.0347864.ref002","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.ento.49.061802.123422","article-title":"Venezuelan equine encephalitis","volume":"49","author":"SC Weaver","year":"2004","journal-title":"Annu Rev Entomol"},{"issue":"0","key":"pone.0347864.ref003","first-page":"79","article-title":"Venezuelan equine encephalitis","volume":"18","author":"KM Johnson","year":"1974","journal-title":"Adv Vet Sci Comp Med"},{"key":"pone.0347864.ref004","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1016\/S0264-410X(02)00300-6","article-title":"Overview: cause and prevention in biowarfare and bioterrorism","volume":"20","author":"MR Hilleman","year":"2002","journal-title":"Vaccine"},{"issue":"2","key":"pone.0347864.ref005","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/CMR.14.2.364-381.2001","article-title":"Bioterrorism: implications for the clinical microbiologist","volume":"14","author":"WF Klietmann","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"pone.0347864.ref006","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.micro.55.1.235","article-title":"Biological weapons--a primer for microbiologists","volume":"55","author":"RJ Hawley","year":"2001","journal-title":"Annu Rev Microbiol"},{"issue":"3","key":"pone.0347864.ref007","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/QCO.0000000000000539","article-title":"Monoclonal antibody-based therapies for bacterial infections","volume":"32","author":"MP Motley","year":"2019","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"pone.0347864.ref008","first-page":"1","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"27","author":"R-M Lu","year":"2020","journal-title":"J Biomed Sci"},{"issue":"15","key":"pone.0347864.ref009","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.cell.2022.05.029","article-title":"Designing antibodies as therapeutics","volume":"185","author":"PJ Carter","year":"2022","journal-title":"Cell"},{"key":"pone.0347864.ref010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-med-052422-020316","article-title":"Treatments for COVID-19","volume":"75","author":"HS Andrews","year":"2024","journal-title":"Annu Rev Med"},{"issue":"12","key":"pone.0347864.ref011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008157","article-title":"Therapeutic monoclonal antibody treatment protects nonhuman primates from severe Venezuelan equine encephalitis virus disease after aerosol exposure","volume":"15","author":"CW Burke","year":"2019","journal-title":"PLoS Pathog"},{"issue":"2","key":"pone.0347864.ref012","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nbt.1521","article-title":"Antigen-specific human polyclonal antibodies from hyperimmunized cattle","volume":"27","author":"Y Kuroiwa","year":"2009","journal-title":"Nat Biotechnol"},{"issue":"3","key":"pone.0347864.ref013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090383","article-title":"Triple immunoglobulin gene knockout transchromosomic cattle: bovine lambda cluster deletion and its effect on fully human polyclonal antibody production","volume":"9","author":"H Matsushita","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"pone.0347864.ref014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130699","article-title":"Species-Specific Chromosome Engineering Greatly Improves Fully Human Polyclonal Antibody Production Profile in Cattle","volume":"10","author":"H Matsushita","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"pone.0347864.ref015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S1473-3099(18)30002-1","article-title":"Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study","volume":"18","author":"JH Beigel","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"pone.0347864.ref016","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/infdis\/jiae369","article-title":"Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial","volume":"230","author":"KW Chew","year":"2024","journal-title":"J Infect Dis"},{"issue":"14","key":"pone.0347864.ref017","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00226-17","article-title":"Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus","volume":"91","author":"CL Gardner","year":"2017","journal-title":"J Virol"},{"issue":"10","key":"pone.0347864.ref018","doi-asserted-by":"crossref","first-page":"107764","DOI":"10.1016\/j.isci.2023.107764","article-title":"Transchromosomic bovine-derived anti-SARS-CoV-2 polyclonal human antibodies protects hACE2 transgenic hamsters against multiple variants","volume":"26","author":"T Gilliland","year":"2023","journal-title":"iScience"},{"key":"pone.0347864.ref019","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiy377","article-title":"Fully human immunoglobulin G from transchromosomic bovines treats nonhuman primates infected with Ebola virus Makona isolate","volume":"218","author":"T Luke","year":"2018","journal-title":"J Infect Dis"},{"issue":"326","key":"pone.0347864.ref020","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf1061","article-title":"Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo","volume":"8","author":"T Luke","year":"2016","journal-title":"Sci Transl Med"},{"key":"pone.0347864.ref021","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3389\/fmicb.2020.00832","article-title":"Anti-HFRS Human IgG Produced in Transchromosomic Bovines Has Potent Hantavirus Neutralizing Activity and Is Protective in Animal Models","volume":"11","author":"CC Perley","year":"2020","journal-title":"Front Microbiol"},{"issue":"10","key":"pone.0347864.ref022","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1002\/jmv.27907","article-title":"Transchromosomic bovines-derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS-CoV-2, MERS-CoV, Ebola, Zika, HIV-1, and influenza A virus","volume":"94","author":"AA Saied","year":"2022","journal-title":"J Med Virol"},{"issue":"14","key":"pone.0347864.ref023","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00226-17","article-title":"Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus","volume":"91","author":"CL Gardner","year":"2017","journal-title":"J Virol"},{"issue":"9","key":"pone.0347864.ref024","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/v11090807","article-title":"Approach to Strain Selection and the Propagation of Viral Stocks for Venezuelan Equine Encephalitis Virus Vaccine Efficacy Testing under the Animal Rule","volume":"11","author":"JM Rusnak","year":"2019","journal-title":"Viruses"},{"issue":"5","key":"pone.0347864.ref025","doi-asserted-by":"crossref","first-page":"380","DOI":"10.30802\/AALAS-CM-18-000027","article-title":"Comparison of Aerosol- and Percutaneous-acquired Venezuelan Equine Encephalitis in Humans and Nonhuman Primates for Suitability in Predicting Clinical Efficacy under the Animal Rule","volume":"68","author":"JM Rusnak","year":"2018","journal-title":"Comp Med"},{"issue":"1","key":"pone.0347864.ref026","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0042-6822(89)90526-6","article-title":"In vitro synthesis of infectious venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant","volume":"171","author":"NL Davis","year":"1989","journal-title":"Virology"},{"issue":"1","key":"pone.0347864.ref027","doi-asserted-by":"crossref","DOI":"10.3390\/v15010005","article-title":"In Vitro and In Vivo Phenotypes of Venezuelan, Eastern and Western Equine Encephalitis Viruses Derived from cDNA Clones of Human Isolates","volume":"15","author":"CL Gardner","year":"2022","journal-title":"Viruses"},{"issue":"6","key":"pone.0347864.ref028","article-title":"Long-term persistence of viral RNA and inflammation in the CNS of macaques exposed to aerosolized Venezuelan equine encephalitis virus","volume":"18","author":"H Ma","year":"2022","journal-title":"PLoS Pathog"},{"issue":"4","key":"pone.0347864.ref029","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1128\/JVI.02990-13","article-title":"Stable, high-level expression of reporter proteins from improved alphavirus expression vectors to track replication and dissemination during encephalitic and arthritogenic disease","volume":"88","author":"C Sun","year":"2014","journal-title":"J Virol"},{"issue":"818","key":"pone.0347864.ref030","article-title":"An inactivated trivalent virion-based vaccine protects against aerosol challenge with encephalitic alphaviruses in mice and macaques","volume":"17","author":"LKM Lam","year":"2025","journal-title":"Sci Transl Med"},{"issue":"3","key":"pone.0347864.ref031","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1086\/519391","article-title":"Severe encephalitis in cynomolgus macaques exposed to aerosolized Eastern equine encephalitis virus","volume":"196","author":"DS Reed","year":"2007","journal-title":"J Infect Dis"},{"issue":"6","key":"pone.0347864.ref032","article-title":"Applications of minimally invasive multimodal telemetry for continuous monitoring of brain function and intracranial pressure in macaques with acute viral encephalitis","volume":"15","author":"H Ma","year":"2020","journal-title":"PLoS One"},{"issue":"17","key":"pone.0347864.ref033","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.00747-19","article-title":"A Vibrating Mesh Nebulizer as an Alternative to the Collison Three-Jet Nebulizer for Infectious Disease Aerobiology","volume":"85","author":"JD Bowling","year":"2019","journal-title":"Appl Environ Microbiol"},{"key":"pone.0347864.ref034","first-page":"163","article-title":"Infectious disease aerobiology: miasma incarnate","volume":"2","author":"CJ Roy","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"pone.0347864.ref035","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.3390\/v15122351","article-title":"Defining the Cynomolgus Macaque (Macaca fascicularis) Animal Model for Aerosolized Venezuelan Equine Encephalitis: Importance of Challenge Dose and Viral Subtype","volume":"15","author":"CW Burke","year":"2023","journal-title":"Viruses"},{"key":"pone.0347864.ref036","doi-asserted-by":"crossref","first-page":"104875","DOI":"10.1016\/j.antiviral.2020.104875","article-title":"Comparative pathology study of Venezuelan, eastern, and western equine encephalitis viruses in non-human primates","volume":"182","author":"DR Smith","year":"2020","journal-title":"Antiviral Res"},{"issue":"38","key":"pone.0347864.ref037","doi-asserted-by":"crossref","first-page":"16026","DOI":"10.1073\/pnas.1110617108","article-title":"Heparan sulfate binding by natural eastern equine encephalitis viruses promotes neurovirulence","volume":"108","author":"CL Gardner","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7487","key":"pone.0347864.ref038","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nature12869","article-title":"RNA viruses can hijack vertebrate microRNAs to suppress innate immunity","volume":"506","author":"DW Trobaugh","year":"2014","journal-title":"Nature"},{"issue":"2","key":"pone.0347864.ref039","article-title":"Physiological and immunological changes in the brain associated with lethal eastern equine encephalitis virus in macaques","volume":"17","author":"JR Albe","year":"2021","journal-title":"PLoS Pathog"},{"issue":"7","key":"pone.0347864.ref040","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.3390\/v14071502","article-title":"Efficacy of Western, Eastern, and Venezuelan Equine Encephalitis (WEVEE) Virus-Replicon Particle (VRP) Vaccine against WEEV in a Non-Human Primate Animal Model","volume":"14","author":"CW Burke","year":"2022","journal-title":"Viruses"},{"issue":"5","key":"pone.0347864.ref041","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1177\/0300985810372508","article-title":"REVIEW PAPER: pathology of animal models of alphavirus encephalitis","volume":"47","author":"KE Steele","year":"2010","journal-title":"Vet Pathol"},{"issue":"4","key":"pone.0347864.ref042","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3390\/pathogens8040240","article-title":"Electrocardiography Abnormalities in Macaques after Infection with Encephalitic Alphaviruses","volume":"8","author":"H Ma","year":"2019","journal-title":"Pathogens"},{"issue":"5","key":"pone.0347864.ref043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010081","article-title":"Eastern equine encephalitis virus rapidly infects and disseminates in the brain and spinal cord of cynomolgus macaques following aerosol challenge","volume":"16","author":"JA Williams","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"pone.0347864.ref044","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20212532","article-title":"Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge","volume":"219","author":"NM Kafai","year":"2022","journal-title":"J Exp Med"},{"issue":"17","key":"pone.0347864.ref045","article-title":"Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope","volume":"184","author":"AS Kim","year":"2021","journal-title":"Cell"},{"issue":"12","key":"pone.0347864.ref046","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2023.05.019","article-title":"Vaccine elicitation and structural basis for antibody protection against alphaviruses","volume":"186","author":"MS Sutton","year":"2023","journal-title":"Cell"},{"key":"pone.0347864.ref047","first-page":"194","article-title":"Alphaviruses","volume-title":"Fields Virology: Emerging Viruses","author":"DE Griffin","year":"2020","edition":"7"},{"issue":"264","key":"pone.0347864.ref048","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010082","article-title":"DNA vaccine-derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome","volume":"6","author":"JW Hooper","year":"2014","journal-title":"Sci Transl Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0347864","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:24:28Z","timestamp":1777310668000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0347864"}},"subtitle":[],"editor":[{"given":"Mauricio","family":"Comas-Garcia","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0347864","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]}}}